# Avalyn Pharma Inc. (AVLN) · Edgar & Edgarette company card

> Figures from the company's own SEC filings.

SEC CIK 1540171 · fiscal year ended — · 0 audited years read · [page](https://www.pops4.com/boards/company/AVLN) · [JSON](https://www.pops4.com/boards/company/AVLN.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | — |
| Revenue growth, 1 year | — |
| Revenue growth per year | — |
| Operating margin | — |
| Net margin | — |
| Operating cash flow | — |
| Capital spending | — |
| Free cash flow | — |
| Cash | — |
| Long-term debt | — |
| Total assets | — |
| Total equity | — |
| Equity ÷ assets | — |
| Return on equity | — |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures


## Edgarette's reading

The filings carry no annual revenue line Edgarette can read (common for banks and insurers, which report income differently). Nothing weighed, nothing guessed.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 1, latest 2026-09-16 ([filing](https://www.sec.gov/Archives/edgar/data/1540171/000119312526393081/0001193125-26-393081-index.htm))

## Recent filings

- 8-K · filed 2026-09-16 · 5.02 Departure or Election of Directors; Appointment of Officers · [filing](https://www.sec.gov/Archives/edgar/data/1540171/000119312526393081/0001193125-26-393081-index.htm)
- 10-Q · filed 2026-08-12 · [filing](https://www.sec.gov/Archives/edgar/data/1540171/000119312526345820/0001193125-26-345820-index.htm)
- 8-K · filed 2026-08-12 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1540171/000119312526345807/0001193125-26-345807-index.htm)
- 8-K · filed 2026-07-01 · 1.01 Entry into a Material Definitive Agreement; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1540171/000119312526292834/0001193125-26-292834-index.htm)
- 8-K · filed 2026-06-17 · 7.01 Regulation FD Disclosure · [filing](https://www.sec.gov/Archives/edgar/data/1540171/000119312526273405/0001193125-26-273405-index.htm)
- 10-Q · filed 2026-06-03 · [filing](https://www.sec.gov/Archives/edgar/data/1540171/000119312526254623/0001193125-26-254623-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001540171.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1540171

## Cite

POPS4, Edgar & Edgarette: Avalyn Pharma Inc. (AVLN) company card, from the company's own SEC filings, accessed 2026-11-04, https://www.pops4.com/boards/company/AVLN. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.